DAX23.535 -0,6%ESt505.445 -0,4%Top 10 Crypto15,13 -0,9%Dow45.947 -0,4%Nas22.385 -0,5%Bitcoin93.720 +0,3%Euro1,1678 +0,1%Öl69,50 -0,2%Gold3.742 -0,2%

FSD Pharma B Aktie

Kaufen

Verkaufen

Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)

Bei einem anderen Broker handeln

Smartphone

WKNA2PTUT

ISINCA35954B2066

SymbolHUGE

FSD Pharma B Aktien News

Sortieren:Datum Meistgelesen

26.08.23BusinesswireFSD Pharma Rebuts Claims of GBB Drink Lab now acquired by Jupiter Wellness Inc. Trading under the symbol (NASDAQ: JUPW)

17.07.23BusinesswireArbitration Panel Finds that Syneos Health (NASDAQ: SYNH) Failed to Use Commercially Reasonable Efforts in Conducting its Trial for FSD 201

10.07.23BusinesswireFSD Pharma Retains Christian Attar Law and Team of Experts to Lead Preliminary Investigation of Possible Naked Short Selling and Manipulation in its stock

04.07.23BusinesswireFSD Pharma Appoints Zeeshan Saeed as Chief Executive Officer, Anthony Durkacz to Serve as Executive Co-Chairman of the Board of Directors

30.06.23BusinesswireFSD Pharma Inc. Announces Results of Annual General and Special Meeting of Shareholders

20.06.23BusinesswireFSD Pharma Announces Agreement to Grant Exclusive Rights to Revolutionary Recreational Alcohol Misuse Technology

25.05.23BusinesswireFSD Pharma Appoints Former Ontario Minister of Health Doctor Eric Hoskins to Board of Directors

12.05.23BusinesswireFSD Pharma Announces Receipt of Court Action and Update on Spin-Out and Distribution

11.05.23BusinesswireFSD Pharma Awarded $2.81 Million in Cost Awards From Dr. Raza Bokhari

08.05.23BusinesswireFSD Pharma to Present at Sidoti Virtual Investor Conference May 10-11

17.04.23BusinesswireFSD Pharma Achieves Milestone in Completion of Dosing of Sentinel Subjects in First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple Sclerosis

12.04.23PR NewswireIIROC Trade Resumption - HUGE

12.04.23PR NewswireIIROC Trade Resumption - HUGE

12.04.23PR NewswireIIROC Trading Halt - HUGE

12.04.23PR NewswireIIROC Trading Halt - HUGE

12.04.23BusinesswireFSD Pharma Announces Plan to Spin-Out Subsidiary as Distribution to Shareholders; Shareholder Meeting Scheduled for June 29, 2023

30.03.23BusinesswireFSD Pharma Adds Former Celsius Holdings CEO Gerry David to Board of Advisors

22.03.23BusinesswireFSD Pharma Announces Its Australian Entity Receives Approval to Proceed With Phase 1 Clinical Trial of Lucid-201, a Candidate for the Potential Treatment of Major Depressive Disorder

28.02.23BusinesswireOriginal "Shark” and Iconic Entrepreneur Kevin Harrington Joins FSD Pharma Advisory Board

15.02.23BusinesswireFSD Pharma Regains Compliance with NASDAQ Continued Listing Requirements

14.02.23BusinesswireFSD Pharma Launches A New Research and Development Program Targeting Unmet Medical Needs for Alcohol Misuse

07.02.23BusinesswireFSD Pharma Receives Regulatory Clearance for Its Proposed Phase-1 Clinical Trial of Lucid-21-302 (Lucid-MS), First-in-Class Multiple Sclerosis Drug Candidate

30.01.23BusinesswireRecruiting Underway in FSD Pharma’s Phase 2 Trial of FSD-PEA (FSD201) for the Treatment of Chronic Pain Associated With Idiopathic MCAS (MCAD)

17.01.23BusinesswireFSD Pharma submits its phase-1 Clinical Trial Application for Lucid-MS (Lucid-21-302) for first-in-human safety and tolerability investigation

13.01.23BusinesswireFSD Pharma Announces Share Repurchase Program

28.11.22BusinesswireFSD Pharma Announces Changes to the Board of Directors

10.11.22BusinesswireFSD Pharma Announces Arbitrator Dismisses Claims by Former CEO, Dr. Raza Bokhari

29.09.22BusinesswireFSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

FSD Pharma B News

FSD Pharma B News: auf dieser Seite finden Sie alle FSD Pharma B News und Nachrichten zur FSD Pharma B Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch FSD Pharma B News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um FSD Pharma B News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.